Israeli COVID-19 Vaccine Developments Webinar – Wednesday, May 6, 2020
May 5, 2020On Wednesday, May 6, 2020, from 12:00pm-1:00pm (Eastern) the Maryland/Israel Development Center will hold a webinar, “Israeli COVID-19 Vaccine Developments.” The event will discuss how Israel has mobilized its scientific and technological talents to address COVID-19, and will feature the following speakers:
- Yaky Yanai, CEO of Pluristem Therapeutics, who is working on a placenta-based cell therapy treatment for respiratory and inflammatory complications associated with COVID-19.
- Vered Kaplan, CEO of Orgenesis, a global biotech company, which is unlocking the potential of cell and gene therapy including anti-viral technologies relevant for COVID-19 to provide life changing personalized medical treatments at the point-of-care to patients.
- Dr. Mark Levitt, Medical Director from RedHill Biopharma, a specialty biopharmaceutical company that is working on an experimental drug, Opaganib, which has shown anti-viral and anti-inflammatory properties to help reduce lung inflammation in COVID-19 patients.
Zoom information will be given upon registration. For more information contact, bbogage@marylandisrael.org. To register: https://midcisraelcovid19.eventbrite.com